LONDON, Sept. 5, 2023 /CNW/ -- The International Health business of Cigna Healthcare, the global health benefits provider of The Cigna Group (NYSE: CI) announced the launch of a new, customized health benefits plan aimed at supporting the health and vitality of globally mobile people aged 60 and older.
The 'Cigna Healthcare Global Plan for Seniors' is designed to meet growing consumer demand and supports new Cigna Healthcare research forecasting that the market is expected to reach 450,000 people by 2025.
In addition to a range of health, well-being, and preventive care services, the 'Cigna Healthcare Global Plan for Seniors' provides essential coverage for hospital stays, inpatient and outpatient mental health treatment, and vaccinations. Medical and pharmacy care for hypertension, type 2 diabetes, glaucoma, arthritis, joint or back pain, and osteoporosis/osteopenia can also be included. There is no age limit, ensuring people are covered for as long as needed. Key benefits also include:
Ross Walker, Chief Commercial Officer for Cigna Global Individual Health, said: "We constantly challenge ourselves to help people live healthier, fuller lives at every stage of life. This health plan is customized for globally mobile seniors, it is affordable, and packed with health and well-being benefits to help people enjoy life wherever it takes them."
For more information visit: International Health Insurance for Seniors | Cigna Healthcare (cignaglobal.com)
About Cigna Healthcare's European businesses ('Cigna Europe')
Cigna Healthcare is part of The Cigna Group (NYSE:CI), a global health service company with roots in the US, serving more than 180 million customers and patients throughout the world. We deliver quality health care and health services through choice, predictability, affordability and through integrated solutions. We have more than 60 years of experience in designing, implementing and managing international group health insurance and employee benefits programs for European corporations, International Organisations (IGO & NGO) and governments. We also provide health services for globally mobile individuals. To support our customers, Cigna Healthcare has dedicated offices in the United Kingdom, Belgium, Spain, Kenya, Dubai, the United States and Malaysia. Over the years, we have acquired an in-depth understanding of the daily challenges faced by international organisations, and their staff members in managing their Whole Health.
Last Trade: | US$334.39 |
Daily Volume: | 0 |
Market Cap: | US$93.010B |
June 12, 2025 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load